133 related articles for article (PubMed ID: 6265413)
21. [Multimodality therapy for small-cell lung cancer].
Yokoyama A
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():405-11. PubMed ID: 9369915
[TBL] [Abstract][Full Text] [Related]
22. Etoposide after ACO treatment for small-cell bronchogenic carcinoma.
Essers U; Knechten H; Seelis R; Ammon J
Cancer Treat Rev; 1982 Jun; 9 Suppl():111-3. PubMed ID: 6290054
[No Abstract] [Full Text] [Related]
23. [Late intensive chemotherapy with bone marrow autograft. Pilot study in small cell bronchial cancer].
Sculier JP; Klastersky J; Stryckmans P
Presse Med; 1983 Mar; 12(11):677-80. PubMed ID: 6300826
[TBL] [Abstract][Full Text] [Related]
24. Integration of chemotherapy and radiation therapy for small cell carcinoma of the lung.
Holoye PY; Libnoch JA; Byhardt RW; Cox JD
Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1593-6. PubMed ID: 6292144
[TBL] [Abstract][Full Text] [Related]
25. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
Work E; Nielsen OS; Bentzen SM; Fode K; Palshof T
J Clin Oncol; 1997 Sep; 15(9):3030-7. PubMed ID: 9294465
[TBL] [Abstract][Full Text] [Related]
26. Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study.
Livingston RB; Crowley JJ; Thompson T; Williamson SK; Meyers FJ; O'Rourke T; Neefe JR
Cancer; 1993 Jun; 71(11):3509-13. PubMed ID: 8387881
[TBL] [Abstract][Full Text] [Related]
27. Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study.
Livingston RB; Moore TN; Heilbrun L; Bottomley R; Lehane D; Rivkin SE; Thigpen T
Ann Intern Med; 1978 Feb; 88(2):194-9. PubMed ID: 204239
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
29. [General hyperthermia in the chemoradiotherapy of small-cell lung cancer].
Zhavrid EA; Sachivko NV; Fradkin SZ; Rud'ko AS
Vopr Onkol; 1991; 37(9-10):962-7. PubMed ID: 1668807
[TBL] [Abstract][Full Text] [Related]
30. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
Murray N; Livingston RB; Shepherd FA; James K; Zee B; Langleben A; Kraut M; Bearden J; Goodwin JW; Grafton C; Turrisi A; Walde D; Croft H; Osoba D; Ottaway J; Gandara D
J Clin Oncol; 1999 Aug; 17(8):2300-8. PubMed ID: 10561291
[TBL] [Abstract][Full Text] [Related]
31. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC
Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
[TBL] [Abstract][Full Text] [Related]
32. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
Furuse K; Fukuoka M; Nishiwaki Y; Kurita Y; Watanabe K; Noda K; Ariyoshi Y; Tamura T; Saijo N
J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and prognostic staging system for small cell lung cancer.
Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
[TBL] [Abstract][Full Text] [Related]
34. Patient with extensive small cell lung cancer given moderately dose-intensified chemotherapy and peripheral blood stem cell support.
Shimizu E; Takaue Y; Yamamoto A; Ogura T; Sone S
Jpn J Clin Oncol; 1995 Oct; 25(5):213-7. PubMed ID: 7474410
[TBL] [Abstract][Full Text] [Related]
35. Limited small cell lung cancer: prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiation.
Armstrong JG; Rosenstein MM; Scher HI; Fass DE; Zelefsky MJ; Kris MG
Radiology; 1991 Mar; 178(3):875-8. PubMed ID: 1847240
[TBL] [Abstract][Full Text] [Related]
36. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):807-11. PubMed ID: 7860392
[TBL] [Abstract][Full Text] [Related]
37. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy of small cell carcinoma of the lung: comparison of a cyclic alternative combination with simultaneous combinations of four and seven agents.
Alberto P; Berchtold W; Sonntag R; Barrelet L; Jungi F; Martz G; Obrecht P
Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1027-33. PubMed ID: 6276185
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
